Emerging Economies and Diabetes and Cardiovascular Disease-Reference-Cited by-同舟云学术

Emerging Economies and Diabetes and Cardiovascular Disease

Published:2012-06 Issue:S1 Volume:14 Page:S-59-S-67
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Pradeepa Rajendra¹,Prabhakaran Dorairaj²,Mohan Viswanathan¹

Affiliation:

1. Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, WHO Collaborating Centre for Noncommunicable Diseases Prevention and Control, International Diabetes Federation Centre for Education, Chennai, India.

2. Centre for Chronic Disease Control and Center for Cardiometabolic Risk Reduction in South Asia (CARRS) Center of Excellence, Public Health Foundation of India, New Delhi, India.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2012.0065

Reference65 articles.

1. A global view on the development of non communicable diseases

2. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries

3. 4. Unwin N, Whiting D, Guariguata L, Ghyoot G, Gan D, eds. Diabetes Atlas, 5thed. Brussels: International Diabetes Federation, 2011:11–74.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ALDH2 polymorphism and myocardial infarction: From alcohol metabolism to redox regulation;Pharmacology & Therapeutics;2024-07

2. Health poverty among people with type 2 diabetes mellitus (T2DM) in Malaysia;Social Science & Medicine;2024-01

3. Novel Approaches for Early Diagnosis and Prevention of Cardiometabolic Diseases;Journal of Clinical and Preventive Cardiology;2023-01

4. Comparison of cardiac autonomic function across complete glycaemic spectrum;Journal of Basic and Clinical Physiology and Pharmacology;2022-05-18

5. Impact of lifestyle diseases on income and household consumption: evidence from an emerging economy;Health Marketing Quarterly;2021-01-02